SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer

Overview of attention for article published in Frontiers in Pharmacology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,226 followers.

E' ancora molto lontano dalla realtà di tutti i giorni (siamo ai test in vitro e sui topi)... Però, ricercatori Cinesi potrebbero aver individuato un inibitore EGFR di 3° generazione, l'SH-1028, che superi la resistenza indotta dalla mutazione T790M‼️ htt

20 May 2021

Reply Repost Favourite

New article: SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer https://t.co/0hCxofEBJL #lungcancer #oncology https://t.co/RGajIBm2ja

14 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.